200 related articles for article (PubMed ID: 9829404)
1. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs.
Ricketts AP; Lundy KM; Seibel SB
Am J Vet Res; 1998 Nov; 59(11):1441-6. PubMed ID: 9829404
[TBL] [Abstract][Full Text] [Related]
2. Possible inconsistencies in study on cyclooxygenase.
Kay-Mugford T; Conlon P
Am J Vet Res; 1999 Mar; 60(3):275-6. PubMed ID: 10188806
[No Abstract] [Full Text] [Related]
3. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
Brideau C; Van Staden C; Chan CC
Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020
[TBL] [Abstract][Full Text] [Related]
5. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs.
Wilson JE; Chandrasekharan NV; Westover KD; Eager KB; Simmons DL
Am J Vet Res; 2004 Jun; 65(6):810-8. PubMed ID: 15198222
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
8. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.
Curnock AP; Robson PA; Yea CM; Moss D; Gadher S; Thomson TA; Westwood R; Ruuth E; Williamson RA
J Pharmacol Exp Ther; 1997 Jul; 282(1):339-47. PubMed ID: 9223572
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs.
Patrignani P; Panara MR; Sciulli MG; Santini G; Renda G; Patrono C
J Physiol Pharmacol; 1997 Dec; 48(4):623-31. PubMed ID: 9444611
[TBL] [Abstract][Full Text] [Related]
10. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
11. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases.
Neupert W; Brugger R; Euchenhofer C; Brune K; Geisslinger G
Br J Pharmacol; 1997 Oct; 122(3):487-92. PubMed ID: 9351505
[TBL] [Abstract][Full Text] [Related]
12. Function of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin.
Coceani F; Ackerley C; Seidlitz E; Kelsey L
Br J Pharmacol; 2001 Jan; 132(1):241-51. PubMed ID: 11156583
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat.
Jett MF; Ramesha CS; Brown CD; Chiu S; Emmett C; Voronin T; Sun T; O'Yang C; Hunter JC; Eglen RM; Johnson RM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1288-97. PubMed ID: 10027870
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs.
Kay-Mugford P; Benn SJ; LaMarre J; Conlon P
Am J Vet Res; 2000 Jul; 61(7):802-10. PubMed ID: 10895904
[TBL] [Abstract][Full Text] [Related]
17. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P
Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922
[TBL] [Abstract][Full Text] [Related]
18. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood.
Streppa HK; Jones CJ; Budsberg SC
Am J Vet Res; 2002 Jan; 63(1):91-4. PubMed ID: 16206787
[TBL] [Abstract][Full Text] [Related]
20. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
van Haeringen NJ; van Sorge AA; Van Delft JL; Carballosa Coré-Bodelier VM
J Ocul Pharmacol Ther; 2000 Aug; 16(4):345-52. PubMed ID: 10977130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
